Stock market announcement archive

June 12, 2024
Reference is made to the stock exchange announcement published by Lifecare ASA (the “Company”) on 30 May 2024, regarding the commencement of the subscription period in the partially underwritten rights issue (the “Rights Issue”). Hannibal Invest AS, a company closely associated with Hans Hekland, member of the board of directors of, and primary insider in, […]
Read more
June 10, 2024
Reference is made to the stock exchange announcement published by Lifecare ASA (the “Company”) on 30 May 2024, regarding the commencement of the subscription period in the partially underwritten rights issue (the “Rights Issue”). Member of the Board of Directors in Lifecare ASA and primary insider Tone Kvåle has today subscribed 40,000 shares in the […]
Read more
June 10, 2024
Bergen, Norway, June 10th, 2024: Today, Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), announces that the company have improved the read-out distance from sensor to the read-out device. Reference is made to previous communications in the Q1 reporting regarding the need to improve the read-out […]
Read more
June 7, 2024
Reference is made to the stock exchange announcement published by Lifecare ASA (the “Company”) on 30 May 2024, regarding the commencement of the subscription period in the partially underwritten rights issue (the “Rights Issue”). Teigland Eiendom AS, a company closely associated with Trine Teigland, board member of the Company, has today sold 8,086,774 subscription rights […]
Read more
June 7, 2024
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE’S REPUBLIC OF CHINA, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT INFORMATION AT THE END OF […]
Read more
June 6, 2024
Reference is made to the stock exchange announcement published by Lifecare ASA (the “Company”) on 30 May 2024, regarding the commencement of the subscription period in the partially underwritten rights issue (the “Rights Issue”). Member of the Board of Directors in Lifecare ASA and primary insider Tone Kvåle has today acquired 40 000 subscription rights […]
Read more
June 6, 2024
Bergen, Norway, June 6th, 2024: Today, Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), announces that the company has concluded the sterilization protocol for production preparations, to be implemented in the automated sensor production. The Lifecare organization is working on preparations for automated production after a […]
Read more
June 4, 2024
Reference is made to the stock exchange announcement published by Lifecare ASA (the “Company”) on 30 May 2024, regarding the commencement of the subscription period in the partially underwritten rights issue (the “Rights Issue”). Teigland Eiendom AS has today exercised 2,623,948 subscription rights in the Rights Issue. Please see the attached PDMR-forms related to the […]
Read more
June 4, 2024
Bergen, Norway, June 4th, 2024: Today, Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), announces that the company has filed an application for a new patent to the European Patent Office (EPO). Reference is made to previous communication of the potential of the sensor technology beyond […]
Read more
May 30, 2024
Reference is made to the stock exchange announcement published by Lifecare ASA (the “Company”) on 30 May 2024, regarding the commencement of the subscription period in the partially underwritten rights issue (the “Rights Issue”). Please see the attached PDMR-forms related to allocation of subscription rights to primary insiders and close associates of primary insiders in […]
Read more